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Research
Particulate matter (PM) air pollution is a
global public health problem (Cohen et al.
2004). In developing countries, levels of air-
borne PM still reach concentrations at which
serious health consequences are well docu-
mented (Chhabra et al. 2001; Ostro et al.
1999a, 1999b; Vichit-Vadakan et al. 2001).
In developed countries, recent epidemiologic
studies show evidence of continued adverse
effects, even though PM levels have declined
in the last two decades (Dominici et al. 2006;
Jerrett et al. 2005; Laden et al. 2006; Pope
et al. 2002). Increased mortality associated
with higher levels of PM air pollution has
been of particular concern, giving an impera-
tive for stronger protective regulations
(Bachmann 2007; Samet et al. 2006).
The evidence on PM and health shows
acute and chronic effects (Pope and Dockery
2006). The London Fog of 1952 provides dra-
matic evidence of the risk of extremely high
levels of PM air pollution over a period of
about a week (Bell and Davis 2001; Bell et al.
2004; Logan 1953). Multisite time-series stud-
ies estimate associations between the risk of
death and the level of air pollution shortly
before death (shorter-term effects). These stud-
ies have provided evidence that far lower levels
of PM than those that occur during events like
the London Fog are still associated with
increased risk over several days (Dominici et al.
2006, 2007; Katsouyanni et al. 1997; Lee et al.
2000; Samoli et al. 2001). Cohort studies esti-
mate associations between time to death and
exposure to air pollution over multiple years
(longer-term effects). The design of these stud-
ies involves follow-up of cohorts for mortality
over periods of years to decades and an assess-
ment of mortality risk in association with esti-
mated longer-term exposure to air pollution
(Dockery et al. 1993; Hoek et al. 2002; Jerrett
et al. 2005; Krewski et al. 2004; Laden et al.
2006; Pope et al. 1995, 2002). The exposure
indicator in these studies was long-term aver-
age air pollution concentration, and time-vary-
ing exposures were not used, except in the
most recent updates of several cohorts (Laden
et al. 2006; Pope et al. 2002). Hence, infer-
ences about the relative risks of chronic expo-
sure derive from comparisons across study
cohorts in geographic units with differing
long-term PM levels.
Künzli et al. (2001) have reviewed and
compared time-series studies and cohort stud-
ies. They point out that air pollution might
increase a) the risk of underlying diseases lead-
ing to frailty and the shorter-term risk of death
among frail persons, b) the risk of chronic dis-
eases leading to frailty but without relation to
timing of death, and c) the shorter-term risk of
death among frail persons but unrelated to risk
of chronic diseases. They note that time-series
studies capture items a and c but do not pro-
vide any information on item b; can be
affected by confounding bias due to lack of
control of time-varying covariates; and are use-
ful to establish causation and to assess relative
magnitude of effects across subgroups. On the
other hand, Künzli et al. (2001) note that
cohort studies capture items a and b but, in the
absence of time-varying exposure, provide very
little information on item c; can be affected by
ecologic bias due to comparison of mortality
risks across heterogeneous groups; and can be
used to estimate years of life lost.
Because of their complexity and costs, only
a small number of cohort studies have been
conducted. The most rigorously executed,
including the Harvard Six Cities Study and the
American Cancer Society’s Cancer Prevention
Study II (CPS-II), have provided generally
consistent evidence for an association between
average exposure to PM air pollution over a
decade and increased all-cause and cardiorespi-
ratory mortality (Dockery et al. 1993; Laden
et al. 2006; Pope et al. 1995, 2002). Both
studies compared mortality rates across coun-
ties or larger geographic units with different
long-term PM levels to estimate relative risks.
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BACKGROUND: Prospective cohort studies constitute the major source of evidence about the mortality
effects of chronic exposure to particulate air pollution. Additional studies are needed to provide
evidence on the health effects of chronic exposure to particulate matter ≤ 2.5 µm in aerodynamic
diameter (PM2.5) because few studies have been carried out and the cohorts have not been
representative.
OBJECTIVES: This study was designed to estimate the relative risk of death associated with long-
term exposure to PM2.5 by region and age groups in a U.S. population of elderly, for the period
2000–2005.
METHODS: By linking PM2.5 monitoring data to the Medicare billing claims by ZIP code of resi-
dence of the enrollees, we have developed a new retrospective cohort study, the Medicare Cohort
Air Pollution Study. The study population comprises 13.2 million participants living in 4,568 ZIP
codes having centroids within 6 miles of a PM2.5 monitor. We estimated relative risks adjusted by
socioeconomic status and smoking by ﬁtting log-linear regression models.
RESULTS: In the eastern and central regions, a 10-µg/m3 increase in 6-year average of PM2.5 is asso-
ciated with 6.8% [95% confidence interval (CI), 4.9–8.7%] and 13.2% (95% CI, 9.5–16.9)
increases in mortality, respectively. We found no evidence of an association in the western region or
for persons ≥ 85 years of age.
CONCLUSIONS: We established a cohort of Medicare participants for investigating air pollution and
mortality on longer-term time frames. Chronic exposure to PM2.5 was associated with mortality in
the eastern and central regions, but not in the western United States.
KEY WORDS: ecologic bias, fine particulate matter (PM2.5), heterogeneity, log-linear models,
Medicare, mortality, prospective studies. Environ Health Perspect 116:1614–1619 (2008).
doi:10.1289/ehp.11449 available via http://dx.doi.org/ [Online 12 August 2008]The results of these studies, rather than of the
time-series studies, have been used to quantify
the risks of PM exposure for consideration of
alternative values for the U.S. National
Ambient Air Quality Standard for PM [U.S.
Environmental Protection Agency (EPA)
2003]. These results have also been used to
estimate the global burden of disease attribut-
able to air pollution (Cohen et al. 2005).
Additional cohort studies are needed to
conﬁrm associations between multiyear aver-
age exposure to PM and mortality, to broaden
the populations studied, to reduce the degree
of geographic averaging of the exposure mea-
sure—a source of ecologic bias—and to reﬁne
the estimates by regions, age, and socioeco-
nomic status (SES) categories across which
PM exposures may vary. Toward this end, we
have used data from the U.S. Medicare sys-
tem, which covers nearly all persons ≥ 65
years of age in the United States. We linked
Medicare mortality data to the PM2.5 (PM ≤
2.5 µm in aerodynamic diameter) air pollu-
tion monitoring data to create a new retro-
spective cohort study, the Medicare Cohort
Air Pollution Study (MCAPS), a study popu-
lation of 13.2 million persons residing in
4,568 ZIP codes in urban areas having geo-
graphic centroids within 6 miles of a PM2.5
monitor. We have previously described this
general approach and the comparability of
risk estimates based on MCAPS with esti-
mates from the Harvard Six Cities Study and
CPS-II (Eftim et al. 2008). In this article, we
report on the relationship between 6-year
average exposure to PM2.5 and mortality risk
in the MCAPS over the period 2000–2005.
Our objective is to provide new evidence
about the relative risk of death associated with
chronic exposure to urban PM2.5 by region
and age-deﬁned subgroups.
Materials and Methods
MCAPS is a retrospective study of a cohort of
13.2 million persons ≥ 65 years of age
enrolled in the U.S. Medicare system during
the 6-year period 2000–2005. To create the
cohort, we used the Medicare enrollment ﬁle
for the study period, which provides a listing
of all Medicare enrollees, along with demo-
graphic information (age, race, and sex) and
ZIP code of residence. New participants enter
each year as they enroll in Medicare, making
this a “dynamic cohort.”
More speciﬁcally, the cohort consists of all
those ≥ 65 years of age who enrolled in
Medicare between 2000 and 2005 with ZIP
code centroids within 6 miles of a U.S. EPA
PM2.5 monitoring station. Although the
Social Security Administration maintains the
addresses of those enrolled in Medicare, the
Center for Medicaid and Medicare (CMS)
provides an annual report of Medicare
enrollees by ZIP code (often referred to as the
enrollee file). Medicare enrollees enter the
cohort on reaching their 65th birthday or on
1 January 1999 should they be ≥ 65 on that
date. A small number of individuals enroll in
Medicare the year after their 65th birthday,
and those individuals enter the cohort on
January 1 of the year of their enrollment.
Individuals contribute time to the cohort
until they die or are otherwise censored.
Censorship occurs when individuals move to
a ZIP code > 6 miles from a U.S. EPA PM2.5
monitoring station or are no longer reported
in the enrollee ﬁle. We calculated age-speciﬁc
mortality rates as the total number of deaths
occurring within an age group and ZIP code
divided by the total person-years contributed
by that age group and ZIP code.
We obtained the date of death from the
CMS. The date of death is provided to CMS
by the Social Security Administration, rather
than by the National Center for Health
Statistics (NCHS), which maintains the
national death certiﬁcate system. To validate
the mortality data from the CMS, we com-
pared annual age- and sex-adjusted mortality
rates from the CMS with the corresponding
rates calculated from NCHS data for the 250
largest counties for the year 2000. The corre-
lation coefﬁcient was 0.998, indicating a high
level of agreement between the two sources of
mortality data aggregated to the county
level—the finest partition available from the
NCHS—for the 1-year period.
For this article, the outcome measure is
the 6-year (2000–2005) mortality rate for
persons residing within each of 4,568 ZIP
codes for each of three age strata: 65–74,
75–84, and ≥ 85 years of age.
We obtained the PM2.5 data from the U.S.
EPA’s AirData database (http://www.epa.gov/
oar/data/), which included 1,006 monitors for
the period 2000–2005. We calculated mean
annual PM2.5 values for the study period for all
4,568 ZIP codes with centroids within 6 miles
of a monitor with > 10 months of data per
year. If three or more observations were avail-
able for a month, we considered this amount
of data sufficient because PM concentration
was measured every sixth day at many loca-
tions. Because the focus of this study was to
estimate the effect of long-term exposure to
PM2.5, we used a ZIP code 6-year average of
PM2.5 as a measure of the long-term exposure
to PM 2.5 for an individual living within a ZIP
code both during the 6 years of follow-up and
for some time before cohort enrollment. We
omitted the 1999 PM2.5 data because this was
the initial year of the U.S. EPA monitoring
program and coverage was limited.
An advantage of MCAPS is that it com-
prises persons ≥ 65 years of age from nearly all
of the major urban ZIP codes in the United
States, and large numbers of deaths are
reported within each age stratum and region.
We have therefore estimated the age- and
region-speciﬁc relative risks of chronic PM2.5
exposure for a) the eastern region of the
United States, with 2,938 ZIP codes in 421
counties; b) the central region, with 990 ZIP
codes within 185 counties located between the
Mississippi River and the Sierra Nevada range;
and c) the western United States, with 640
ZIP codes within 62 counties extending from
Washington State to Southern California.
Figure 1 shows the location of the 4,568 ZIP
code centroids, the three geographic regions,
and the spatially smoothed levels of the 6-year
average PM2.5. These spatially smoothed
PM2.5 levels should be interpreted with cau-
tion because of the sparseness of monitors in
some areas.
We conducted the analyses separately
within each of these three geographic regions
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Figure 1. Map of spatially smoothed averages of PM2.5 during the study period 2000–2005. The map also
indicates 4,568 ZIP code centroid locations (black circles) and western, central, and eastern U.S. regions. 
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≥ 17and for three distinct age strata: 65–74,
75–84, and ≥ 85 years of age. We also strati-
fied initial analyses by sex and by the ZIP
codes that were above and below the national
median for education and income variables.
Because the estimated effects for men and
women and for high- and low-SES subgroups
were very similar, we did not stratify the
analyses reported here by sex or SES. The
results of these stratiﬁed analyses are available
in the Supplemental Material, Table 1 (online
at http://www.ehponline.org/members/2008/
11449/suppl.pdf).
In estimating the effect on mortality of
PM or other air pollutants, previous cohort
studies and this new study rely entirely on
cross-sectional comparisons of covariate-
adjusted mortality rates across geographic
locations with different PM levels, because
PM is not time varying in the analyses.
Previous studies have accounted for potential
confounding by a) individual-level lifestyle
factors, including age and smoking, and
b) area-level characteristics such as county-
level SES. The MCAPS provides individual-
level age, sex, and race data but not data on
lifestyle factors. To account for SES at the ZIP
code level, we used age-speciﬁc SES variables
from the 2000 U.S. Census. After preliminary
analysis, we selected ﬁve SES variables at the
ZIP code level from the U.S. Census Bureau’s
Summary File 3. We restricted the analysis to
those enrollees who report ZIP codes to CMS
that correspond to ZIP code tabulation areas
recognized by the U.S. Census Bureau. We
selected two education variables, percentage of
the population with a high school diploma
and the percentage with a higher education
degree, along with two household income
measures, percentage of households living
below the poverty level and median household
income, as well as percentage unemployed. To
create a univariate measure of SES by which to
stratify the analysis, we averaged the ranks of
the ﬁve SES variables for each county.
Previous cohort studies have found little
effect of adjusting for self-reported smoking
status (Krewski et al. 2000). Area-level differ-
ences in cigarette smoking, however, could
potentially confound the association between
PM2.5 and mortality. Because the MCAPS
data have neither individual- nor area-level
smoking information, we used data from the
NCHS to calculate the standardized mortality
ratio (SMR) for chronic obstructive pul-
monary disease (COPD) for the period
1993–2002, adjusted for age, race, and sex for
each county. Because the vast majority of
deaths from COPD in the United States are
attributable to smoking (U.S. Department of
Health and Human Services 2004), we used
the SMR for COPD as a surrogate indicator
of the long-term smoking pattern of its resi-
dents. We included the county-level COPD
SMR in the regression model, assigning the
county value to all ZIP codes within a county.
For exposure, reliance on ZIP code–level
rather than county-level PM concentration is
a strength, but person-level covariate informa-
tion is unavailable. To assess the potential
consequences of imperfect control for con-
founding variables, we estimated the main
models with three levels of adjustment: no
control for ZIP code–level confounders, con-
trol for ZIP code–level SES variables, and
control for ZIP code–level SES and county-
level COPD SMRs.
Within each age stratum, we estimated
the following log-linear regression models
(McCullagh and Nelder 1989):
logE(Yi) = logNi + β0 + βPMZi + βXXi,[ 1 ]
where Yi, Ni, Zi, and Xi are the number of
deaths, number of person-years at risk, PM2.5,
and SES and COPD SMR for ZIP code i.
The parameter βPM denotes the log relative
risk of mortality associated with a 1-µg/m3
difference in average PM2.5 comparing ZIP
codes that are otherwise similar with respect
to SES and COPD SMR.
We report results for each region by age
stratum and aggregated over the three age
groups. To obtain the aggregated value, we ﬁt
a single log-linear regression with a common
PM effect across the strata. We use general-
ized estimating equations (Diggle et al. 2002)
to account for the correlation among age
groups from the same ZIP code.
We carried out all analyses with the statis-
tical programs R (R Development Core
Team, Vienna, Austria) and SAS (version 9.1;
SAS Institute Inc., Cary, NC). Programs are
available from the authors.
Results
Table 1 presents the total number of ZIP
codes, PM2.5 monitors, study population,
person-years of follow-up, number of deaths,
and crude death rates for the eastern, central,
and western regions. The study population
comprises 19.1 million persons followed for a
total of 92.6 million person-years or an aver-
age of 4.8 years per person. An individual can
contribute person-time to two age categories,
so the age-speciﬁc numbers of people do not
add to the total size of the population. There
were 4.88 million deaths, for a crude mortal-
ity rate of 52.6 deaths per 1,000 person-years.
The crude mortality in the western region was
lower by roughly 4 deaths per 1,000 person-
years compared with the other two regions,
reﬂecting its younger population.
Table 2 presents the median and inter-
quartile range of the ZIP code values of aver-
age PM2.5 for 2000–2005, ﬁve SES variables,
Zeger et al.
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Table 1. Numbers of ZIP codes, counties, monitoring sites, Medicare enrollees, person-years of follow-up,
deaths, and crude death rates stratiﬁed by region and age group for MCAPS.
U.S. region
Characteristic Eastern Central Western All
ZIP codes 2,938 990 640 4,568
Counties 421 185 62 668
Monitoring sites 613 280 119 1,006
Persons (millions) 12.5 3.7 3.1 19.1
65–74 years 7.7 2.3 1.9 11.9
75–84 years 5.9 1.7 1.4 8.9
≥ 85 years 2.4 0.7 0.6 3.6
Person-years (millions) 61.1 17.2 14.4 92.6
65–74 years 30.2 8.8 7.3 46.3
75–84 years 22.6 6.2 5.3 34.1
≥ 85 years 8.2 2.2 1.9 12.3
Deaths (millions) 3.26 0.91 0.70 4.88
65–74 years 0.77 0.22 0.16 1.66
75–84 years 1.31 0.36 0.28 1.95
≥ 85 years 1.18 0.33 0.26 1.77
Crude death rate (deaths/1,000 person-years) 53.4 53.1 48.8 52.6
65–74 years 25.6 25.3 22.4 25.0
75–84 years 57.8 58.7 53.3 57.2
≥ 85 years 143.6 148.9 139.1 143.9
Table 2. Median (interquartile range) ZIP code–level SES values, median county-level COPD SMR, and
median ZIP code–level PM2.5, by region in MCAPS.
U.S. region
Characteristic Eastern Central Western All 
Percent with high school degree 50.0 (41.8–56.0) 49.6 (42.1–56.1) 44.4 (37.0–51.3) 49.3 (40.8–55.6)
Percent with higher degree 28.0 (19.7–41.9) 29.2 (18.2–43.9) 31.4 (21.0–44.7) 28.7 (19.5–43.0)
Percent in poverty 10.1 (5.5–18.5) 12.4 (6.9–20.6) 12.0 (7.0–19.3) 10.9 (6.0–19.2)
Percent unemployment 5.1 (3.5–8.3) 5.3 (3.6–8.2) 6.4 (4.5–8.9) 5.3 (3.6–8.4)
Median income (thousands US$)  40.6 (31.6–52.6) 37.2 (29.8–48.2) 43.9 (35.0–56.4) 40.4 (31.5–52.3)
COPD SMR 94.0 (84.0–108.7) 109.2 (95.2–101.9) 101.9 (100.5–115.0) 99.6 (88.6–113.3)
PM2.5 (μg/m3) 14.0 (12.3–15.3) 10.7 (9.8–12.2) 13.1 (10.4–18.5) 13.2 (11.1–14.9)and COPD SMRs by region. A scatterplot
matrix [see Supplemental Material, Figure 1
(online at http://www.ehponline.org/members/
2008/11449/suppl.pdf)] provides an X–Y
graph for each variable against each other vari-
able. The proportions have been transformed
to the log odds (logit) scale {log[p/(1 – p)]} to
allow them to range over the whole real line
rather than in (0,1); we show SES variables on
a log scale to linearize their associations with
mortality and to reduce the impact of a few
ZIP codes with larger average incomes. The
bottom row of Table 2 shows the pattern of
pairwise associations between the logit of mor-
tality and each of the covariates or PM2.5. As
expected, mortality has a strong negative asso-
ciation with each of the SES variables and a
positive association with COPD SMRs.
Table 3 presents the estimated relative
risks stratified by region. The MCAPS data
provide evidence of an association between
long-term exposure to PM2.5 and mortality in
the eastern and central regions. For the east-
ern ZIP codes, we found that a ZIP code with
10 µg/m3 higher long-term average of PM2.5
compared with another ZIP code with com-
parable age distribution, SES, and COPD
SMR has a 6.8% higher mortality [95% con-
ﬁdence interval (CI), 4.9–8.7]. For the central
ZIP codes, a 10-µg/m3 increase in the long-
term average of PM2.5 is associated with a
13.2% increase in mortality (95% CI,
9.5–16.9). For the ZIP codes in the western
region, the association between PM2.5 and
mortality does not achieve statistical signifi-
cance. In the eastern region, adjustment for
SES and COPD SMR substantially attenuates
the association from 15.5% down to 6.8%
per 10 µg/m3increase. 
Table 4 presents the estimated region-
speciﬁc log relative risks of death for each of
the three age groups. In the western region,
there is no evidence of an association for any
of the three age groups. In the eastern and
central regions, the largest effect is for the
youngest group, 65- to 74-year-olds (11.4%
and 20.4% per 10-µg/m3 increase, respec-
tively). The effects are smaller for the 75- to
84-year-olds and close to 0 for the oldest
group, those ≥ 85 years of age. Hence, there is
no evidence of a PM effect for persons ≥ 85
years of age in any of the three regions.
We verified the sensitivity of the infer-
ences to the speciﬁc choice of model used to
control for SES and COPD mortality rate,
and the results are qualitatively robust, as
shown in Table 3. We also conducted analy-
ses stratified by sex and by ZIP codes above
and below the national median for education
and income variables. We found that the esti-
mated effects for men and women and for
high- and low-SES subgroups were very simi-
lar. We report the results of these analyses in
the Supplemental Material, Table 1 (online at
http://www.ehponline.org/members/
2008/11449/suppl.pdf).
Discussion
In this article we present results from MCAPS,
the largest study of potential health effects of
chronic exposure to air pollution on morbidity
and mortality to date, with 4.88 million deaths
during more than 92 million person-years of
follow-up. In comparison, a total of 20,765
deaths in the subcohort of the American
Cancer Society (Krewski et al. 2000) were
included in the analyses of air pollution and
mortality, less than one-tenth the number in
our study. However, CPS-II had an extensive
set of individual-level risk factors. Given the
availability of 1,006 air pollution monitors and
mortality data from 4,568 ZIP codes within
668 urban counties, we have stratified the
analyses geographically, choosing strata that
broadly reflected differing source mixes and
background disease patterns. This stratiﬁcation
also controls for potential confounders that
vary on broad geographic scales.
Our estimated associations between long-
term exposure to PM2.5 and mortality for the
eastern and central ZIP codes give results
qualitatively similar to those previously pub-
lished from the Six Cities Study (Dockery
et al. 1993) and CPS-II (Pope et al. 2002).
We previously reported the comparability of
MCAPS estimates to estimates from these
studies, with the MCAPS cohort restricted to
the 110 and the 6 counties corresponding to
the 50 metropolitan areas and the 6 counties
included in CPS-II and the Six Cities Study,
respectively (Eftim et al. 2008). The MCAPS
relative risk estimates, based on the 4,568 ZIP
codes, are 11.4% and 20.4% per 10-µg/m3
increase in the eastern and central regions
(95% CI, 8.8–14.1% and 15.0–25.8%,
respectively) for the youngest age group, com-
pared with the Six Cities Study and CPS-II
values of 15.3% and 12.4%, respectively.
Although the MCAPS data lack individual-
level risk factor information, the MCAPS
results were not qualitatively changed with
inclusion of ZIP code–level or county-level
SES indicators and the COPD SMR in the
log-linear regression model (Tables 3 and 4).
The size of the positive estimates does change
with control for SES and COPD SMRs in the
eastern region.
In MCAPS, we found compelling evi-
dence of differing PM relative risks by age
and geographic location. MCAPS estimates of
the PM relative risk decline with increasing
age category (Table 4), with no evidence of an
association among persons ≥ 85 years of age.
This decline may reﬂect the many competing
causes of death for which the hazard of death
increases with age. If only a subset of the
competing causes is inﬂuenced by exposure to
PM, then the PM-associated relative risk will
reduce with age.
The MCAPS results indicate that the esti-
mated positive association between PM2.5
concentration and mortality derives entirely
from the eastern and central United States. A
provocative finding is that the MCAPS data
show no evidence of a positive association
between ZIP code–level PM2.5 and mortality
rates for the 640 urban ZIP codes in the west-
ern region. This lack of association is largely
because the Los Angeles basin counties
(California) have higher PM levels than other
Mortality risks from chronic exposure to fine particulate matter
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Table 3. Percentage increase (95% CI) in mortality rate per 10-μg/m3 increase in PM2.5 from the log-linear
regression model and stratiﬁed by three regions, and relative risks for three levels of adjustment for demo-
graphic and socioeconomic variables.
U.S. region
Adjustment Eastern (n = 2,938 ZIP codes) Central (n = 990 ZIP codes) Western (n = 640 ZIP codes)
Age 15.5(13.0 to 18.0) 17.8(13.3 to 22.2) 0.3(–1.9 to 2.5)
Age + SES 10.5(8.4 to 12.5) 8.9(5.2 to 12.5) –0.3(–2.2 to 1.6)
Age + SES + COPD 6.8(4.9 to 8.7) 13.2(9.5 to 16.9) –1.1(–3.0 to 0.8)
Table 4. Percentage increase (95% CI) in mortality rate per 10-μg/m3 increase in PM2.5 from log-linear regres-
sion using MCAPS regional data adjusting for three levels of demographic and socioeconomic variables.
Age group (years)
U.S. region/adjustment All 65–74 75–84 ≥ 85
Eastern
Age 15.5 (13.0 to 18.0) 31.1 (26.8 to 35.5) 17.6 (14.9 to 20.4) –1.4 (–3.5 to 0.8)
Age + SES 10.5 (8.4 to 12.5) 17.3 (14.6 to 20.0) 12.4 (10.1 to 14.6) 1.4 (–0.7 to 3.5)
Age + SES + COPD 6.8 (4.9 to 8.7) 11.4 (8.8 to 14.1) 8.9 (6.8 to 11.0) 1.7 (–0.3 to 3.7)
Central
Age 17.8 (13.3 to 22.2) 39.0 (29.7 to 48.2) 17.5 (12.7 to 22.2) –2.1 (–5.9 to 1.6)
Age + SES 8.9 (5.2 to 12.5) 16.5 (10.9 to 22.1) 8.8 (4.6 to 13.0) –0.7 (–4.2 to 2.8)
Age + SES + COPD 13.2 (9.5 to 16.9) 20.4 (15.0 to 25.8) 12.0 (7.6 to 16.4) –0.3 (–4.0 to 3.3)
Western
Age 0.3 (–1.9 to 2.5) 6.0 (2.3 to 9.6) 0.4 (–2.0 to 2.7) –5.2 (–7.2 to 3.2)
Age + SES –0.3 (–2.2 to 1.6) –2.1 (–5.0 to 0.8) 0.3 (–1.8 to 2.5) 0.9 (–0.8 to 2.7)
Age + SES + COPD –1.1 (–3.0 to 0.8) –1.5 (–4.2 to 1.1) –0.2 (–2.2 to 1.9) –0.5 (–2.5 to 1.5)West Coast urban centers, but not higher
adjusted mortality rates.
Recent multisite time-series studies of the
same Medicare data also suggest that the
effects of airborne PM vary by region and sea-
son. In a study of cause-speciﬁc cardiovascular
and respiratory hospital admissions and daily
PM2.5 levels in Medicare enrollees, Dominici
et al. (2006) found strong regional patterns of
effect across the 204 U.S. counties included
during the period 1999–2002. Effect esti-
mates for most of the cardiovascular causes
were statistically significant in the eastern
United States, but not in the western United
States. These results were confirmed by a
recent study (Bell ML et al., in press) that
covered the period 2000–2005.
Previous studies of the mortality effects of
chronic PM exposure or surrogates for popu-
lations in the western region have reported a
range of relative risks. Most recently, Jerrett
et al. (2005) investigated the PM–mortality
association in a subset of the CPS-II cohort
living in Los Angeles. They estimated an 11%
increase in mortality per 10-µg/m3 increase
PM2.5 (95% CI, –1% to 25%), using a
chronic PM exposure interpolated with a sta-
tistical model of measured PM, traffic pat-
terns, and proximity to freeways. Abbey et al.
(1999) reported a follow-up analysis of data
from the Adventist Health Study (Hodgkin
et al. 1984) of > 6,000 nonsmoking residents
of three air basins in California—San
Francisco, Los Angeles, and San Diego—
enrolled in 1977. They found a nonsignifi-
cant increase in all-cause deaths of roughly
5% per 10-µg/m3 increase PM10 (PM with
aerodynamic diameter < 10 µm) in males and
no effect in females. They reported a statisti-
cally significant association in respiratory
deaths with the fraction of days > 100 µg/m3
PM10 for both sexes. Enstrom (2005) tracked
mortality from 1973 through 2002 in about
50,000 California participants in the first
national cohort study carried out by the
American Cancer Society. Using PM2.5 data
for 11 counties in 1979–1983, he found no
association across the full follow-up period
and evidence of a small effect during the ﬁrst
decade of follow-up. Misclassiﬁcation arising
from the limited exposure data available may
have biased this study toward the null.
Regional differences in effect estimates
may be related to heterogeneity in the PM
mixture. For example, higher PM2.5 sulfate
levels are observed in the eastern United
States and higher PM2.5 nitrate in the western
United States. A recent analysis of the chemi-
cal composition of PM2.5 from 2000 to 2005
characterized seasonal and regional variation
for > 50 chemical components (Bell et al.
2007); several other studies have investigated
the chemical composition of PM in specific
regions of the United States (Ostro et al., in
press; Shen et al. 2007; Subramanian et al.
2007; Vega et al. 2007; Viana et al. 2008). 
The relative risks estimated in this study
might be affected by ecologic bias due to
using aggregate rather than individual-level
air pollution exposure and confounding fac-
tors. We estimate long-term exposure by tak-
ing averages of PM2.5 concentrations during
the study period 2000–2005 for each of the
1,006 monitors. We then assign this monitor-
speciﬁc long-term average to the ZIP code of
residence of each enrollees with a centroid
located within 6 miles from the monitor. Bias
in a cross-sectional study such as this one can
occur if the difference between average per-
sonal PM exposure in a ZIP code and the
average ambient value used in this study
covaries with PM levels across the region after
adjusting for SES and COPD SMRs. By
including only ZIP codes whose centroids
were within 6 miles of a monitor as the units
of analysis, we used exposure values that are,
on average, geographically closer to residences
and thus reduced the potential for this type of
ecologic bias.
In a few cohort studies, exposures have
been estimated at the individual level using
models and residence location (Hoek et al.
2002; Jerrett et al. 2005). This approach can
assign person-specific estimates of exposure,
potentially reducing the effects of exposure
measurement error, depending upon the
accuracy and precision of the exposure model.
No cohort studies have measured personal
exposure directly because this is not feasible
with current technologies.
For MCAPS, the covariate information
about SES was available only at the ZIP code
level. Smoking data were represented by the
COPD SMR for the county of residence,
because the direct data on prevalence were
unavailable. With the data reported here, we
cannot directly evaluate the potential for eco-
logic bias from these terms. However, Krewski
et al. (2000) have done so for CPS-II and the
Six Cities Study by comparing relative risks
with and without controlling for individual-
level characteristics, including smoking, exer-
cise, education, and occupational exposures.
They found little change in the PM relative
risk with adjustment, suggesting that ecologic
bias is negligible for those personal characteris-
tics measured in these two cohort studies.
Despite these methodologic complexities,
we have shown that a cohort can be estab-
lished using Medicare participants and rou-
tine monitoring data for investigating air
pollution and mortality on longer-term time
frames. In our initial analyses of the MCAPS
data, we confirmed the association between
PM2.5 and mortality found in other studies
but we found substantial and unexplained
geographic heterogeneity in the effect of
PM2.5 across the United States.
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